Drug Topics
AUGUST 28, 2023
A recent systematic review found no serious adverse events related to the use of cannabis for the management of cancer-related symptoms in children.
Pharmacy Times
AUGUST 28, 2023
Advanced technology can automate many pharmacovigilance tasks to build workflow efficiencies, reduce manual intervention, and free up team members for more strategic activities.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
AUGUST 28, 2023
A recent study found that there was a lack of strong evidence supporting the use of continuous glucose monitor programs in community pharmacies.
Pharmacy Times
AUGUST 28, 2023
Although the patient demographics are similar for the 3 categories of hemolytic reactions with intravenous immunoglobulin, the reaction with delayed hemolytic transfusion reactions was highest compared to the other 2 hemolytic reactions.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
AUGUST 28, 2023
Researchers believe a recent study shows how living in neighborhoods with high and very high levels of opportunity in early life is associated with lower asthma incidence in childhood.
Pharmacy Times
AUGUST 28, 2023
Perhaps the most significant development in the pharmaceutical industry in decades, crops of biosimilars are being approved and are ready for distribution. What lies next, in terms of legislation and the impact on pharmacists, remains to be seen.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
AUGUST 28, 2023
With the help of new and complex algorithms and self-learning models, we are currently privy to what we may look back on as the golden era of AI.
Fierce Healthcare
AUGUST 28, 2023
Blue Cross Blue Shield of Massachusetts announced< | Blue Cross Blue Shield of Massachusetts tapped Paul Long to serve as the health plan’s chief consumer experience officer.
Pharmacy Times
AUGUST 28, 2023
KET01 could successfully treat treatment-resistant depression while limiting adverse effects in the home environment, according to the study.
Fierce Healthcare
AUGUST 28, 2023
Rite Aid is reportedly preparing to file for bankruptcy within a few weeks to help restructure its debt and potentially halt ongoing lawsuits. | The bankruptcy would reportedly pause the many legal claims against the retailer and allow it to consolidate and resolve them in one place.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
AUGUST 28, 2023
Pharmacists' expertise is invaluable to prescribers who are unfamiliar with opioid use disorder treatment protocols.
Fierce Pharma
AUGUST 28, 2023
It’s a sale. Two months after Abcam launched a strategic review of the company, the British antibody research expert has revealed that it’s being bought by Danaher. | Danaher Corporation is picking up all outstanding shares of Abcam for $24 apiece. Both companies’ boards unanimously approved the decision, Danaher and Abcam said Monday. The deal is expected to close in mid-2024.
Pharmacy Times
AUGUST 28, 2023
The start date of the package-level electronic tracking system will shift from November 27, 2023 to November 27, 2024.
Fierce Pharma
AUGUST 28, 2023
With seven posters and nine presentations on Farxiga over the weekend at the European Society of Cardiology (ESC) scientific sessions in Amsterdam, AstraZeneca made it clear that it has lots to say | As AstraZeneca's Farxiga has added four indications over the last five years—on top of its initial 2014 approval for Type 2 diabetes—its spillover benefits have become apparent and yielded a better understanding of the interconnections between Type 2 diabetes, heart failure and chronic kidney d
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
AUGUST 28, 2023
The federal government has started penalizing Medicare Advantage insurers that have one common, glaring problem: Faulty technology systems are leading to people paying more for care and coverage than they should be. The Centers for Medicare and Medicaid Services fined three different Medicare Advantage plans this month, each one getting dinged differently for the way they overcharged their members.
The Checkup by Singlecare
AUGUST 28, 2023
Benadryl , or diphenhydramine hydrochloride in its generic form, is an antihistamine commonly prescribed to treat allergy symptoms like a runny nose, sneezing, or itching. Additionally, brand-name Benadryl is an antiemetic, which means it can help reduce nausea and vomiting, and it can be used as a sleep aid or anti-anxiety medication (thanks to its side effect of drowsiness).
STAT
AUGUST 28, 2023
Over the past year, weight loss drugs have captured the public’s imagination but also raised existential questions about the future of bariatric surgery. For obesity, surgery has long been — and continues to be — the most effective treatment, reducing patients’ risk of sleep apnea, diabetes, cancer, cardiovascular disease, and death.
Fierce Healthcare
AUGUST 28, 2023
L.A. Care Health Plan is investing $4.05 million in a street medicine initiative to expand access to care for unsheltered people. | Nine organizations offering street medicine services will each receive up to $500,000 from the health plan. The program aims to beef up street medicine teams serving LA, as well as to ensure people without stable housing do not drop off Medi-Cal amid Medicaid redeterminations.
STAT
AUGUST 28, 2023
When you’re a psychiatrist, there’s no such thing as a typical day. But if you’re working in a clinic setting (like one of us, Jessi, is currently, and the other, Simone, has done previously), one thing is for sure: You’re busy. And it’s not just about seeing patients — it’s the seemingly ever-increasing electronic messages.
Fierce Healthcare
AUGUST 28, 2023
Bon Secours Mercy Health took its ongoing spat with regional Elevance Health plans to the next level on Monday, filing suit against the insurer alleging that it owed more than $93 million in unpaid | Bon Secours Mercy Health took its ongoing spat with regional Elevance Health plans to the next level on Monday, filing suit against the insurer alleging that it owed more than $93 million in unpaid claims.
Fierce Pharma
AUGUST 28, 2023
Echoing an earlier move in the United Arab Emirates, CDMO National Resilience is again growing its presence in the Middle East. | CDMO National Resilience the latest drugmaker to set down roots in Saudi Arabia, following in the footsteps of Sanofi and Merck KGaA.
Fierce Healthcare
AUGUST 28, 2023
As health plans drop costly GLP-1 drugs, controversially leaving people without access to potentially life-changing therapies, health companies are hoping to fill the marketplace void to provide be | Obesity impacts roughly 40% of Americans, but insurers are becoming less willing to cover weight loss drugs for the disease. Health companies are looking to bridge the gap.
STAT
AUGUST 28, 2023
Long Island is in the midst of a housing crisis. Just like in many other parts of the country, Long Islanders are having a tough time finding affordable housing — an issue that is intimately connected with health. Earlier this year, New York Gov. Kathy Hochul put forth a plan to deal with the housing challenges. Her ambitious goal: to construct 800,000 new homes and apartment units throughout the state over the next decade.
Fierce Pharma
AUGUST 28, 2023
After filing a closely watched lawsuit to block Amgen's proposed takeover of Horizon Therapeutics, the Federal Trade Commission (FTC) is pausing those efforts to consider whether it should settle t | The Federal Trade Commission has paused its challenge of the $27.8 billion merger between Amgen and Horizon Therapeutics to rethink whether it should settle the case.
STAT
AUGUST 28, 2023
In response to growing complaints, the U.S. Food and Drug Administration has postponed its plans to enforce a law designed to thwart counterfeit or diverted medicines passing through the pharmaceutical supply chain. The law was supposed to be fully enforced in late November, but the agency now says it will not take action until November 2024. At issue is the Drug Supply Chain Security Act, which has been implemented in steps over the past decade.
Fierce Pharma
AUGUST 28, 2023
It’s been well documented how Novo Nordisk has had difficulty in meeting the soaring demand for its GLP-1 weight loss treatments. | Amid supply problems, Novo Nordisk plans to launch its GLP--1 drugs in “more and more” countries, CEO Lars Fruergaard Jørgensen said at a recent Reuters event, though he added that the launches will be "constrained.
STAT
AUGUST 28, 2023
Striking moderators of the infectious diseases surveillance website ProMED have been given an ultimatum: Signal their interest in remaining with the program by Wednesday and return to work on Friday, or they will be considered to have “moved on” from the organization. The moderators, subject matter experts who are paid a nominal stipend for curating and contextualizing the numerous infectious diseases reports ProMED posts to its website and pumps out to its mailing list daily, have
Fierce Pharma
AUGUST 28, 2023
As Alnylam persists in its COVID-19 patent litigation, the RNAi specialist has been dealt a blow in one of its lawsuits against Moderna. | As Alnylam persists in its COVID-19 patent litigation, the RNAi specialist has been dealt a blow in one of its lawsuits against Moderna. But Alnylam says it'll appeal the recent ruling.
STAT
AUGUST 28, 2023
CINCINNATI — Brynn Schulte nearly died twice when she was a baby, at one point needing emergency surgery for massive bleeding in her brain. No one knew what was wrong until a test that looked at her full genetic blueprint found a rare bleeding disorder called factor XIII deficiency — an early diagnosis that saved her life.
European Pharmaceutical Review
AUGUST 28, 2023
Novartis has announced that Leqvio ® (inclisiran) , the first and only small interfering RNA (siRNA) therapy indicated to reduce low-density lipoprotein cholesterol (LDL-C), has demonstrated promising long-term results. This is based on three-year follow up data from a Phase III trial, presented at the European Society of Cardiology (ESC) Congress 2023.
Fierce Healthcare
AUGUST 28, 2023
Nationwide hospital finances hit a rough patch in July as reduced patient volumes, a bump in bad debt and charity care whittled operating margins. | Patient volumes, particularly in outpatient settings, saw a steep month-over-month decline while Medicaid redetermination appears to have sparked a bump in bad debt and charity care, per Kaufman Hall.
Drug Store News
AUGUST 28, 2023
Rite Aid is reportedly planning to file for bankruptcy to address federal and state lawsuits it is facing over its alleged role in the sale of opioids, per a WSJ report.
Fierce Pharma
AUGUST 28, 2023
With many medicines from Pfizer’s Rocky Mount, North Carolina, production plant relegated to an emergency ordering list following a devastating tornado last month, hospitals and government health o | With many medicines from Pfizer’s Rocky Mount, North Carolina, production plant relegated to an emergency ordering list following a devastating tornado last month, hospitals are likely eager for the massive injectables facility to restart production.
Pharmacy Times
AUGUST 28, 2023
This technique may be applied to transdermal applications, such as shot-free vaccines.
Expert insights. Personalized for you.
187 
Let's personalize your content